Immune Activation by Double-Stranded Polynucleotides Read more about Immune Activation by Double-Stranded Polynucleotides European Patent99969109.0Filed on 1999-09-10
Synthetic Macrolides Compounds And Methods For Treating Cancer Read more about Synthetic Macrolides Compounds And Methods For Treating Cancer US Application 12/526,477Filed on 2009-08-07
Synthetic Macrocyclic Compounds Read more about Synthetic Macrocyclic Compounds European Patent08729310.6Filed on 2008-02-07
USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT Read more about USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT Hong Kong04106574.7Filed on 2004-09-01
The Use Of Leptin For Treating Human Lipotrophy Read more about The Use Of Leptin For Treating Human Lipotrophy Australia2002359288Filed on 2002-10-22
The Use Of Leptin For Treating Human Lipotrophy Read more about The Use Of Leptin For Treating Human Lipotrophy Mexico2007/006095Filed on 2007-05-14
The Use Of Leptin For Treating Human Lipoatrophy Read more about The Use Of Leptin For Treating Human Lipoatrophy US Application 11/606,805Filed on 2006-11-29
The Use Of Leptin For Treating Human Lipotrophy Read more about The Use Of Leptin For Treating Human Lipotrophy US Patent 7,183,254Filed on 2003-07-18
Delivery Of Cross Species A3 Adenosine-receptor Antagonist To Reduce Intracoular Pressure Read more about Delivery Of Cross Species A3 Adenosine-receptor Antagonist To Reduce Intracoular Pressure US Application 12/419,062Filed on 2009-04-06
Truncated (N)-Methanocarba Adenosine Derivatives As A3 Receptor Antagonists Read more about Truncated (N)-Methanocarba Adenosine Derivatives As A3 Receptor Antagonists Patent Cooperation TreatyPCT/US2009/52439Filed on 2009-07-31